Ultomiris is a medication used for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AchR) antibody-positive as well as those with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).
It is natural to think you are alone when you are diagnosed with PNH, because it is a rare disease. We are here to help you be successful.
Ultomiris is given as an IV infusion every 8 weeks after 2 initial doses.
WARNING:
SERIOUS MENINGOCOCCAL INFECTIONS: Immunize patients with
meningococcal vaccines at least 2 weeks prior to administering the first dose
of Ultomiris.
Meningococcal vaccination (both conjugate and serogroup B) are required
prior to initiating Ultomiris infusions.
We offer expert infusion therapy without the hassle or cost of the hospital. We employ highly trained medical staff that work with health insurance companies & physicians to provide our patients with convenient care.
At Omega Health Clinics, we’re committed to offering affordable treatment, with upfront pricing and no hidden costs. Here’s how we make it happen.
